Prodeon Medical, Inc.
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
Prodeon Medical, Inc. designs minimally invasive treatments for benign prostatic hyperplasia to relieve lower urinary tract symptoms. The effort began in 2016 with the aim of rethinking how men are treated for BPH. Based in Sunnyvale, California, the company operates as a small to mid-sized medical device developer focused on patient-friendly approaches to BPH-related LUTS. The associated procedure is investigational and not for sale in the U.S. or elsewhere, remaining within a clinical trial program. In April 2026, Prodeon Medical announced that three abstracts about its approach would be presented at the American Urological Association Annual Meeting in Washington, D.C.